1 Supplementary Information for : Microfluidics-based diagnostics of infectious diseases in the developing world

One of the great challenges in science and engineering today is to develop technologies to improve the health of people in the poorest regions of the world. Here we integrated new procedures for manufacturing, fluid handling and signal detection in microfluidics into a single, easy-to-use point-of-care (POC) assay that faithfully replicates all steps of ELISA, at a lower total material cost. We performed this 'mChip' assay in Rwanda on hundreds of locally collected human samples. The chip had excellent performance in the diagnosis of HIV using only 1 μl of unprocessed whole blood and an ability to simultaneously diagnose HIV and syphilis with sensitivities and specificities that rival those of reference benchtop assays. Unlike most current rapid tests, the mChip test does not require user interpretation of the signal. Overall, we demonstrate an integrated strategy for miniaturizing complex laboratory assays using microfluidics and nanoparticles to enable POC diagnostics and early detection of infectious diseases in remote settings.

[1]  G. Roselle,et al.  False positive tests for HTLV-III antibodies in alcoholic patients with hepatitis. , 1986, The New England journal of medicine.

[2]  N. Nuwayhid.  Laboratory tests for detection of human immunodeficiency virus type 1 infection , 1995, Clinical and diagnostic laboratory immunology.

[3]  R. Finke,et al.  Transition Metal Nanocluster Formation Kinetic and Mechanistic Studies. A New Mechanism When Hydrogen Is the Reductant: Slow, Continuous Nucleation and Fast Autocatalytic Surface Growth , 1997 .

[4]  R. Varley,et al.  A reassessment of the cost-effectiveness of water and sanitation interventions in programmes for controlling childhood diarrhoea. , 1998, Bulletin of the World Health Organization.

[5]  M. Fowler,et al.  Prevention of mother-to-child HIV transmission in resource-poor countries: translating research into policy and practice. , 2000, JAMA.

[6]  J. Rich,et al.  Laboratory testing for infection with the human immunodeficiency virus: established and novel approaches. , 2000, The American journal of medicine.

[7]  A. Gerbase,et al.  Seroprevalence of HIV, Hepatitis B Virus, and Syphilis in Women at Their First Visit to Public Antenatal Clinics in Vitória, Brazil , 2001, Sexually transmitted diseases.

[8]  S. Quake,et al.  Microfluidic Large-Scale Integration , 2002, Science.

[9]  G. Vercauteren,et al.  Comparative evaluation of eight commercial enzyme linked immunosorbent assays and 14 simple assays for detection of antibodies to HIV. , 2002, Journal of virological methods.

[10]  H. Becker,et al.  Polymer microfluidic devices. , 2002, Talanta.

[11]  George Janossy,et al.  Multiplexed immunoassays by flow cytometry for diagnosis and surveillance of infectious diseases in resource-poor settings. , 2002, The Lancet. Infectious diseases.

[12]  Douglas K. Martin,et al.  Top ten biotechnologies for improving health in developing countries , 2002, Nature Genetics.

[13]  C. Mirkin,et al.  Nanoparticle-Based Bio-Bar Codes for the Ultrasensitive Detection of Proteins , 2003, Science.

[14]  J. Widegren,et al.  A review of the problem of distinguishing true homogeneous catalysis from soluble or other metal-particle heterogeneous catalysis under reducing conditions , 2003 .

[15]  Samuel K Sia,et al.  An integrated approach to a portable and low-cost immunoassay for resource-poor settings. , 2004, Angewandte Chemie.

[16]  R. Finke,et al.  A mechanism for transition-metal nanoparticle self-assembly. , 2005, Journal of the American Chemical Society.

[17]  Samuel K Sia,et al.  Reagent-loaded cartridges for valveless and automated fluid delivery in microfluidic devices. , 2005, Analytical chemistry.

[18]  Kristen L. Helton,et al.  Microfluidic Overview of Global Health Issues Microfluidic Diagnostic Technologies for Global Public Health , 2006 .

[19]  S. Eustace,et al.  General principles. , 2006, Seminars in musculoskeletal radiology.

[20]  Federico Girosi,et al.  Reducing the burden of sexually transmitted infections in resource-limited settings: the role of improved diagnostics , 2006, Nature.

[21]  Rosanna W. Peeling,et al.  Evaluation of diagnostic tests for infectious diseases: general principles , 2006, Nature Reviews Microbiology.

[22]  J Freedson,et al.  Children and armed conflict in the Democratic Republic of the Congo. , 2006 .

[23]  Jeffrey Wasserman,et al.  Global health diagnostics , 2006, Nature.

[24]  C. Haub,et al.  Rwanda Demographic and Health Survey 2005. , 2006 .

[25]  G. Whitesides.  The origins and the future of microfluidics , 2006, Nature.

[26]  R. Peeling,et al.  Why do we need quality-assured diagnostic tests for sexually transmitted infections? , 2006, Nature Reviews Microbiology.

[27]  Jeffrey Chow,et al.  Advancement of global health: key messages from the Disease Control Priorities Project , 2006, The Lancet.

[28]  Chong H. Ahn,et al.  Institute of Physics Publishing Journal of Micromechanics and Microengineering a Review of Microvalves , 2022 .

[29]  Rosanna W. Peeling,et al.  Evaluation of rapid diagnostic tests: syphilis , 2006, Nature Reviews Microbiology.

[30]  N. Sewankambo,et al.  Limitations of rapid HIV-1 tests during screening for trials in Uganda: diagnostic test accuracy study , 2007, BMJ : British Medical Journal.

[31]  Samuel K Sia,et al.  Lab-on-a-chip devices for global health: past studies and future opportunities. , 2007, Lab on a chip.

[32]  I. Dékány,et al.  The kinetics of homogeneous nucleation of silver nanoparticles stabilized by polymers , 2007 .

[33]  O. Velev,et al.  Characterization and optimization of gold nanoparticle-based silver-enhanced immunoassays. , 2007, Analytical chemistry.

[34]  Samuel K Sia,et al.  Effect of volume- and time-based constraints on capture of analytes in microfluidic heterogeneous immunoassays. , 2008, Lab on a chip.

[35]  G. Whitesides,et al.  Simple telemedicine for developing regions: camera phones and paper-based microfluidic devices for real-time, off-site diagnosis. , 2008, Analytical chemistry.

[36]  Andreas Manz,et al.  Micro total analysis systems: latest achievements. , 2008, Analytical chemistry.

[37]  P. Yager,et al.  Point-of-care diagnostics for global health. , 2008, Annual review of biomedical engineering.

[38]  K. Lokuge,et al.  The Evaluation of a Rapid In Situ HIV Confirmation Test in a Programme with a High Failure Rate of the WHO HIV Two-Test Diagnostic Algorithm , 2009, PloS one.

[39]  Geertruida A. Posthuma-Trumpie,et al.  Lateral flow (immuno)assay: its strengths, weaknesses, opportunities and threats. A literature survey , 2009, Analytical and bioanalytical chemistry.

[40]  Arben Merkoçi,et al.  Controlling the electrochemical deposition of silver onto gold nanoparticles: reducing interferences and increasing the sensitivity of magnetoimmuno assays. , 2009, Biosensors & bioelectronics.

[41]  Tassaneewan Laksanasopin,et al.  Microfluidic point-of-care diagnostics for resource-poor environments , 2009, 2009 Annual International Conference of the IEEE Engineering in Medicine and Biology Society.

[42]  C. Delaugerre,et al.  Sensitivity of Five Rapid HIV Tests on Oral Fluid or Finger-Stick Whole Blood: A Real-Time Comparison in a Healthcare Setting , 2010, PloS one.

[43]  Andrew J. deMello,et al.  Microfluidics: Exploiting elephants in the room , 2010, Nature.